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Abstract
Background: Prostate cancer (PCa) represents one of the most common types of
cancers facing the male population. Nowadays, to confirm PCa, systematic or
multiparametric MRI-targeted transrectal or transperineal biopsies of the prostate are
required. However, due to the lack of an accurate imaging technique capable to precisely
locate cancerous cells in the prostate, ultrasound biopsies sample random parts of the
prostate and, therefore, it is possible to miss regions where those cancerous cells are
present. In spite of the improvement with multiparametric MRI, the low reproducibility of
its reading undermines the specificity of the method. Recent development of prostate-
specific radiotracers has grown the interest on using positron emission tomography (PET)
scanners for this purpose, but technological improvements are still required (current
scanners have resolutions in the range of 4–5mm).
Results: The main goal of this work is to improve state-of-the-art PCa imaging and
diagnosis. We have focused our efforts on the design of a novel prostate-dedicated PET
scanner, named ProsPET. This system has small scanner dimensions defined by a ring of
just 41 cm inner diameter. In this work, we report the design, implementation, and
evaluation (both through simulations and real data) of the ProsPET scanner. We have
been able to achieve < 2mm resolution in reconstructed images and high sensitivity. In
addition, we have included a comparison with the Philips Gemini-TF scanner, which is
used for routine imaging of PCa patients. The ProsPET exhibits better contrast, especially
for rod sizes as small as 4.5mm in diameter. Finally, we also show the first reconstructed
image of a PCa patient acquired with the ProsPET.
Conclusions: We have designed and built a prostate specific PET system, with a small
footprint and improved spatial resolution when compared to conventional whole-body
PET scanners. The gamma ray impact within each detector block includes accurate DOI
determination, correcting for the parallax error. The potential role of combined organ-
dedicated prostate-specific membrane antigen (PSMA) PET and ultrasound devices, as a
prebiopsy diagnostic tool, could be used to guide sampling of the most aggressive sites
in the prostate.
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Introduction
Prostate cancer (PCa) is a major worldwide health concern facing the male population.
PCa is the most common type of cancer among men in Europe, which is closely
followed by lung and colorectal cancer, with 1,276,106 cases reported in 2018 and caus-
ing 358,989 deaths (3.8% of all deaths caused by cancer in men) in 2018 [1]. Although
mortality rates are generally high in populations of African descent, intermediate in the
USA, and very low in Asia, a relatively less variation is observed in mortality rates
worldwide [2]. Otherwise, if we consider future epidemiological previsions, 2,293,818
new cases are estimated until 2040, observing therefore a small variation in mortality
(an increase of 1.05%) [3].
The most frequently used method for imaging the prostate is transrectal ultrasound
(TRUS). However, less than 60% of tumors—usually advanced tumors—are visible with
TRUS [4]. Therefore, in clinical diagnosis, grey-scale TRUS is not reliable at detecting
PCa [5]. Thus, there is evidence that US biopsies are useful just in a systematic
approach.
At present, multiparametric magnetic resonance imaging (mpMRI) is increasingly
used to localize suspicious areas that could be targeted by so-called magnetic res-
onance imaging-targeted biopsies. However, in a recent meta-analysis which com-
pared mpMRI to template biopsies (> 20 cores) in biopsy-naive and repeat-biopsy
settings, mpMRI had a pooled sensitivity of 0.91 (95% CI 0.83–0.95) and a pooled
specificity of 0.37 (95% CI 0.29–0.46) for ISUP grade > 2 cancers. For cancers with
International Society of Urological Pathology grade > 3, mpMRI pooled sensitivity
and specificity were 0.95 (95% CI 0.87–0.99) and 0.35 (95% CI 0.26–0.46), respect-
ively [6]. Perhaps this low specificity is due to the poor mpMRI reproducibility and
the reason why the European Guidelines on PCa itself states that “Despite the use
of the PIRADSv2 scoring system, mpMRI inter-reader reproducibility remains mod-
erate at best” [7].
Molecular imaging using positron emission tomography (PET) is an alternative tech-
nique. However, when combined with fluorodeoxyglucose (FDG), the diagnosis of PCa
decreases due to the low and heterogeneous consumption of glucose by PCa [8]. Recent
developments of new PET ligands such as 18F-labeled choline analogs, 11C-acetate, or
18F-fluorodihydrotestosterone have shown promising results in the detection of malig-
nant lesions in PCa [9, 10].
A more advanced solution for diagnosing PCa is to search for PCa-specific antigenic
targets and to generate agents that are able to specifically bind such as the prostate-
specific membrane antigen (PSMA), which is overexpressed in PCa tissue. While
advances in conventional imaging will continue, antibody (Ab) and small molecule im-
aging exemplified by PSMA targeting have the greatest potential to improve diagnostic
sensitivity and specificity [11]. State-of-the-art PET scanners present spatial resolutions
of 3–5 mm, which is in a sharp mismatch with the sizes of the structures and cancerous
lesions that need to be visualized in the prostate and, therefore, these scanners are not
able to detect small tumoral lesions [12]. Interestingly, the spatial resolution require-
ments for a PET, accurate enough for the detection of prostatic lesions, are practically
the same as for small animal models (around 1mm). However, the ultimate limit is im-
posed by the specificity of the imaging agents and uptake in the lesions, while the PET
imager operates at the physical limit of performance [13–15].
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To improve state-of-the-art PCa diagnosis, the proposed imaging system must allow
one for a precise image-based diagnosis and for accurate biopsy guidance. To meet
these requirements, the collaboration with physicians is the key to ensure an optimal
determination of the required dimensions of a prostate-dedicated PET scanner, in
addition to other parameters such as a small footprint in order to be easily moved be-
tween different rooms within the Nuclear Medicine or Radiology departments. In this
work, we describe the design and performance evaluation of a dedicated PET system
for prostate imaging, with a small geometry both in the number of detectors and the
system itself, but with a high performance comparable to whole-body PET scanners.
In the proposed prostate-dedicated scanner, the spatial resolution is almost uniform
across the entire field of view (FOV) due to the implementation of the photon depth of
interaction (DOI) information, which is one of the advantages of using monolithic scin-
tillation crystals for the detector design. We have carried out an evaluation of the
spatial resolution, sensitivity, noise-equivalent count rate (NECR), and image quality of
the proposed geometry. Simulations based on Monte Carlo (MC) of the system have
also been carried out and accordingly compared to the experimental results. Moreover,
a patient was scanned on the prototype with successful results when compared to
standard whole-body PET scanners.
Materials and methods
Scanner geometry
Using MRI images from 22 patients, we have determined the average abdominal di-
mensions at the axial place where the prostate is located. We found a wide size and pa-
tient thickness of 36 cm and 22 cm, respectively (see Fig. 1 left). Considering these
values, the prostate-dedicated PET ring design, named ProsPET, has been designed
with an aperture of about 410mm in diameter. The ProsPET ring includes 24 detector
blocks separated by a thin gap of just 4 mm. Figure 1 right shows a sketch of the ring
geometry and detector positions.
System description
Each one of the 24 detector modules of the ProsPET ring is based on a single mono-
lithic LYSO scintillation crystal of 50 × 50 × 15mm3. All faces have been polished and
Fig. 1 Left, study on patient dimensions. Black squares represent the “wide” measurements, whereas the
red circles are the patient thickness. Right, prostate PET ring dimensions (in mm)
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the four lateral ones (50 × 15 mm2) black painted, in order to reduce undesired internal
reflections. The entrance face of the scintillation block (50 × 50 mm2) was covered with
a retroreflector layer that bounces back the scintillation light to the emission point pre-
serving the light distribution profile [16, 17] while increasing the light collection effi-
ciency. The exit face of the scintillator was coupled by means of optical grease (BC630,
Saint Gobain) to a photosensor array of 12 × 12 SiPMs. In particular, we made use of
silicon photomultiplier (SiPM) arrays of the type C-Series (SensL, now On-Semi) with
3 × 3mm2 active area, 4.2 mm pitch, and 35 microns cell size [18]. A custom readout
electronics based on passive components reduces the 144 SiPM signals to only 24. In
particular, the 12 SiPM signals of each row and column of the photosensor array were
summed and pre-amplified before transferring to the data acquisition system (DAQ).
This readout scheme allows one to characterize the scintillation light distributions in
monolithic crystals [16]. The PET scanner has been assembled without any forced cool-
ing approach, but simply requiring the room to be at a stable temperature in between
20 and 25°C (variation ± 0.5°C). The DAQ system was installed in a cabinet under the
patient’s bed, where the patient is in supine position.
For each detector block, thin multicoaxial cables (SAMTEC) have been used to exchange
the 24 (12 + 12 row and columns) analog signals, the trigger signal (sum of all 24), and the
temperature sensor, as well as the amplifiers and SiPM bias. The trigger logic has been pro-
grammed to digitize signals only when two trigger signals are within a coincidence window
of 5 ns. Charge integrators with a window of 250 ns, and 12-bit precision, are used.
Every detector allows coincidences with its 13 opposite detectors. This defines a
transaxial and axial FOV of about 300 and 46mm, respectively. The axial FOV can be
increased to about 80 mm by axially displacing the ring and allowing certain image
overlapping (multiacquisition process).
In order to facilitate patients to properly position in the bed and into the scanner, the
system has two movable parts that open and close with an accuracy of about 0.5 mm.
In Fig. 2, from left to right, one can see the detector ring when it is open, installed in
the acquisition bed, with a patient in supine position, and an example in the lateral
cubit, respectively.
Calibration data
For every detector block, we run calibration processes of the impact position for both
the planar and DOI coordinates, as well as for the energy. This calibration process is
Fig. 2 Photographs of the scanner. a During assembly showing the movable sections. b Installed together
with the bed. c System representation with a virtual patient. d During an ergonomic test showing the
possibility for rectal biopsies
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either based on 1D polynomials [19] or Voronoi diagrams [20] (see Fig. 3). Similar
image performance is obtained with either method. See reference [20] for a detailed
comparison of both calibration procedures. Planar coordinates are calculated by raising
the 12 digitized signals for each projection to the power of two, before center of gravity
(CoG) calculation. The DOI coordinate is estimated for each event as the average for
rows and columns (r,c) of the ratio of the sum of all 12 signals (photon energy, E) to its
maximum value ( /Imax)r,c, [16]. Independently of the calibration procedure, a con-
tinuous DOI correction for each line of response (LOR) is carried out. After calibration,
list-mode data files are generated, prior to reconstruction.
Simulation platform
We have carried out Monte Carlo simulations of the proposed prostate PET system
using GATE v7.2 [21]. The code source is Geant4. For the simulations, the already de-
scribed LYSO scintillator block was modeled and placed in a ring configuration as
schematically shown in Fig. 1. It has to be mentioned that, for simplicity, we have de-
fined back-to-back (511 keV) sources instead of positron emitter sources and therefore
some variations were expected between the simulation results and the experimental
performance of the detectors.
The simulations results have been used to evaluate the scanner configuration in
terms of sensitivity and NECR performance. We established a time resolution of 3 ns,
and the time coincidence window to 5 ns, mimicking the real scanner. To make the
simulation data more realistic, a Gaussian energy blurring of 15% (based on previous
experiments performed with these blocks [17]) was included, as well as energy windows
of both 30% and 50% (± photopeak position). A paralyzable deadtime of 1 μs was also
considered, as estimated from the real DAQ system.
CASToR reconstruction platform
To reconstruct the list-mode data, we have made use of the CASToR 1.1 platform ver-
sion [22] and the Siddon projector [23]. CASToR is an open source code that enables
to reconstruct not only PET data, but also SPECT and CT as well. CASToR is a generic
application that does not estimate correction factors such as normalization, attenuation,
scattered, or random counts. Therefore, it is necessary to externally introduce the re-
quired correction information.
Fig. 3 Left, photograph of the detector block, photosensor, and frontend electronics. Center, calibrated
flood map of the 11 × 11 sources array used of position calibration. Right, calibrated energy profile of
one detector
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In particular, we have employed the OSEM algorithm (ordered subsets expectation
maximization) with 2 subsets for every reconstruction. The number of iterations has been
optimized for the different measurements as it will be described later. 3D images were gen-
erated in a binary raw file with a matrix size of 416 × 416 × 50 voxels with 1 × 1 × 1mm3
voxel size. Since monolithic crystals allow one to define the pixel size, somehow based on
the measured detector resolution [24], we have selected virtual detector pixels of 1 × 1
mm2, which is also a compromise between statistics and computational cost.
Normalization correction
Normalization coefficients were calculated across the entire FOV using a custom de-
signed phantom which ensures that all system LORs cross it. The designed phantom
consists on a fillable PMMA annulus with inner and outer diameters of 290mm and
300mm (50 mm axial), respectively. This particular geometry helps minimizing the
number of scattered events [25]. The ring was filled with a solution of FDG and an ac-
tivity of 7 mCi and positioned in the center of the FOV. Sequential acquisitions over 9
h were carried out. Figure 4 left shows the ProsPET scanner together with the
normalization phantom and, on the right, the measured normalization map.
Attenuation correction
Attenuation maps were either obtained through CT images acquired in a separated system
(Philips Gemini-TF 64) or by segmentation in the case of uniform phantoms [26]. In the
case of CT-based maps, they were co-registered with the PET acquisitions using a specific
software, called ITK-SNAP [27]. We recalculated all voxels to values considering the linear
attenuation coefficients of each material. For every data acquisition, we have obtained a cor-
rection map that is the combination of the aforementioned normalization and the attenu-
ation one. Figure 5 shows the attenuation and combined attenuation-normalization maps
for the image quality phantom (to be defined later). On the left image, all the white values
are established to 0.096 cm−1, the water value, and the rest are set to 0.
System spatial resolution and sensitivity
All tests were performed without including smoothing filters or random and scatter
corrections. The spatial resolution is defined as the width of the reconstructed image
Fig. 4 Left, photograph of the detectors ring and normalization phantom. Right, normalization
map obtained
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point spread function (PSF), calculated using the full width at half-maximum (FWHM).
Data was acquired using a 0.25 mm in diameter spherical 22Na source. This radioactive
source had an activity of 22 μCi, and thus, the random coincidence rate is almost negli-
gible, as well as the percentage of dead time losses. Each acquisition lasted 10 min. We
designed and constructed holders to place the source in different positions along both
the transaxial and axial axes; see Fig. 6. The source was moved along the radial direc-
tion in steps of 20 mm, both at the center and at 3/8 of the axial FOV.
The optimal number of iterations for the spatial resolution evaluation was studied using
the data acquired when the source was located at the center of the field of view (CFOV).
The data was reconstructed both with and without including DOI information.
Using the same radioactive source, we also evaluated the system sensitivity. A new
holder that allows one to move the source across the axial direction in steps of 5 mm
was designed for this purpose; see Fig. 6. Each measurement lasted 10min.
Quality phantom study
We have evaluated the contrast-to-noise ratio (CNR) and the contrast of reconstructed
images using a custom-made phantom. The CNR was calculated as follows:
Fig. 5 Left, attenuation map of the image quality phantom. Right, combined normalization and attenuation maps
Fig. 6 Left, photograph of the holder and source used for the spatial resolution studies along the radial
axis. Right, holder for the sensitivity measurements
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CNR ¼ Mean Hot Spot VOI-Background
Background Standard Deviation
ð1Þ
The contrast, in percentage, was calculated using the mean value of each VOI and
the background level:
Contrastð%Þ ¼ 100Mean Hot Spot VOI-Background
Mean Hot Spot VOI
ð2Þ
The phantom used in this study, named quality phantom (QP), is made out of
PMMA and has an outer diameter of 135 mm and 103mm height. The QP includes 6
insert tubes with different diameters (4.5, 6, 9, 12, 15, 20 mm) and 60 mm height each,
at an off-center radius of 35 mm [28]. In addition to filling the inserts with FDG, the
background of the phantom was also filled but with a different FDG concentration.
Two insert-to-background concentrations were measured, namely 38 and 18. The ac-
quisition of the phantom images lasted 8 min each.
Both the background level and its standard deviation have been calculated. We have
defined 12 different volumes of interest (VOIs), with the size of the small insert, distrib-
uted along uniform areas of the phantom and obtained the mean value of each one.
Thereafter, we generated 6 VOIs that fit each insert dimensions, but with a centered
height of 25 mm. The CNR and contrast values as a function of the number of itera-
tions were tested after normalization and attenuation corrections.
For comparison purposes, data acquisitions of the QP using the whole-body PET
Gemini-TF 64 (Philips) [29] were carried out about 10 min after the measurements per-
formed with the ProsPET system.
Count rate performance
In PET imaging, effects such as scattered and random coincidences might generate an
image blurring, consequently producing a wrong determination of the radioactive dis-
tribution. The intrinsic radiation of LYSO scintillators might also generate undesired
random events [30]. Therefore, in order to optimize the quality of the image, it is crit-
ical to estimate the percentage of all these losses as a function of the imaged activity.
To study the different contributions, we have used a phantom made out of high-
density polyethylene with 170 mm length and 60 mm in diameter (see Fig. 7c). It was
placed at the scanner center FOV. The phantom has a drilled hole of 3.2 mm in diam-
eter and at 13 mm off-radial direction [24]. Through this hole, a silicone tube (170 mm
Fig. 7 Left, sketch of the QP with positioning of each insert and dimensions (diameters). Center,
photograph of the QP while measuring. Right, photograph of the NECR phantom inside the PET ring
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long) with 1 mm (inner) and 3mm (outer) diameters was inserted and filled with FDG.
The initial activity was 5.45 mCi. We carried out sequential acquisitions every 10 min,
during a total time of 18 h.
For each acquisition, a sinogram was generated, where the true, scatter, and random
counts are estimated following the NEMA NU 4-2008 protocol [31]. For validation pur-
poses, similar data was obtained using GATE v7.2 simulations.
Case example: patient study
Finally, we have tested the ProsPET system with a patient that was diagnosed with PCa.
The patient was injected with 7.5 mCi of a 18F-choline solution. About 90 min post-
injection, the patient was scanned in the Philips Gemini-TF (PET/CT) where each bed
position lasted 90 s. The CT image was used to determine the distance between the top
of the head and the prostate and, therefore, properly positioning the patient within the
ProsPET system. The ProsPET acquisition was carried out 30 min after the whole-body
PET/CT one. This person signed an informed consent form.
For each of the two axial FOVs we acquired 7min data. We applied a smoothing




After the calibration process, we have determined the average measured detector spatial
resolution to be about 1.8 ± 0.4 mm FWHM, combined with an energy resolution of
13.7 ± 1.8 % [17, 18], for all the 24 detectors (see again Fig. 3). A DOI resolution of
about 3.2 ± 0.6 mm FWHM for all detectors and for all detection areas allows one to
continuously correct to the true LOR [32].
PET spatial resolution
All acquired data has been corrected for attenuation and normalization, except in the
case of the spatial resolution results were only the normalization was applied. Figure 8
left shows the FWHM (radial) of the source at the CFOV as a function of the number
Fig. 8 Left, radial FWHM of the source PSF at the CFOV as a function of the number of iterations. Right,
tangential, radial, and axial components (FWHM) of the source as a function of the distance to CFOV in
radial direction, when using 3 iterations
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of iterations. We observe a convergence of the FWHM at 3 iterations. We used this
number of iterations for the reconstruction of the sources along all the other positions
in the radial direction. Figure 8 right depicts the measured FWHM for the three space
components for the plane Z = 0 (axial centered). DOI correction was implemented for
these reconstructions. We observe that the three components are below 2mm FWHM
for all positions, except the radial component that increases to about 2.5 mm at the
very edge of the FOV.
Figure 9 left shows the measured spatial resolution at different radial position when
the source is at the center and at 3/8 (17.25 mm) of the axial FOV. As it can be ob-
served, there is almost no degradation in the spatial resolution for the different axial
positions. Figure 9 right depicts the radial component with and without DOI correc-
tion, making emphasis on the relevance of including 3D photon coordinates informa-
tion. This radial component increases to as much as 4.5 mm FWHM if DOI is not
considered.
Sensitivity
Figure 10 shows the sensitivity profiles as a function of the axial position. As expected,
the maximum sensitivity is found at the center of the axial FOV (25 mm in these plots).
We have used two different energy windows (EW): 30% (357.7 to 664.3 keV) and 50%
(255.5 to 766.5 keV). We have subtracted the background counts. The system achieves
1.46% sensitivity at the scanner center. The sensitivity, estimated by simulations, is also
depicted in this plot for both the 30% and 50% EW, respectively.
Noise-equivalent count rate
Both experimental and simulated data obtained for the NECR phantom were stored in
2D sinograms. After analysis, following the NEMA NU 4-2008 [31], information about
the true, random, and scatter counts was obtained as depicted in Fig. 11. The intrinsic
radiation of the LYSO scintillation block was not implemented during the simulations
but is still present in the experimental data. In order to account for this, we subtracted
the measured background counts to the random and scatter contributions.
Fig. 9 Left, radial FWHM (3 iterations and DOI correction) of the source PSF as a function of the radial
position at the axial center and 3/8 (17.25 mm). Right, radial FWHM (3 iterations) as a function of the radial
position at the axial center, but with (black squares) and without (red circles) DOI correction
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Fig. 10 Sensitivity (%) curves for two energy windows 30% (black open squares) and 50% (red open
circles), respectively, as a function of the reconstructed source position. The solid black square and red circle
exhibit the simulated sensitivity for the 30% and 50% energy windows, respectively
Fig. 11 Top-left, measured values for an activity range from 0 to above 5 mCi. Top-right, comparison
experimental and simulation data for the true counts. Bottom-left, same as before but for NECR. Bottom-
right, same as before but for the sum of random and scatter
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Figure 11 top-left plots the measured prompt, NECR, scatter plus random, and trues
(5 ns CW), as a function of the activity. We observe also in Fig. 11 that both NECR and
true counts exhibit similar values for experimental and simulated data, especially at
lower activities. However, the curves for the random plus scatter events show some de-
viations for high activities.
CNR and contrast results
Following a similar procedure to the one used during the spatial resolution studies, we
have reconstructed the QP using different iterations, as shown in Fig. 12. The recon-
structions accounted for normalization and attenuation corrections. Figure 12 right
shows the CNR for the smallest and largest inserts within the QP. We have decided to
use 8 iterations in the following data analysis, since the background exhibits a mini-
mum at this point.
Figure 13 exhibits the reconstructed QP images. Data acquired with the Gemini-TF
was reconstructed using the BLOB-OSEM-TOF algorithm, with 2 iteration and 33 sub-
sets, including single scatter simulation correction and the delayed window approach
for the random contribution. No average or smooth filters were applied to any image
both for the ProsPET or Gemini-TF.
Figure 14 shows the determined CNR and contrast values for both the ProsPET and
Gemini-TF reconstructions of the custom QP, for both insert-to-background ratios of 38
and 18. The ProsPET reconstruction used 8 iterations without scatter and random correc-
tions applied, but the attenuation correction based on the CT attenuation map. In terms
of the contrast, ProsPET exhibits values higher than 75% for all inserts. Regarding the
CNR, although similar values are obtained for both systems for the smallest inserts, differ-
ences increase with the size of the inserts, being larger for the whole-body PET.
Patient study
Images obtained with the patient also required normalization and attenuation corrections.
We also selected 8 iterations. Figure 15 a and b show the result of the reconstruction if
normalization or attenuation was not considered, respectively. We have co-registered the
CT and the prostate-dedicated PET images and applied the attenuation map with this
Fig. 12 Left, background values as a function of number of iterations. Right, CNR versus number
of iterations
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information; see Fig. 15c. Figure 15d depicts the image of the same patient acquired with
Gemini-TF.
Discussion and conclusions
The diagnostic image of the primary tumor in prostate cancer is still waiting for his
white knight. At present, mpMRI is the imaging modality of choice for precise morpho-
logic evaluation, has higher spatial resolution, and provides clearer anatomic delinea-
tion of the prostate and surrounding anatomical structures than PET, while PSMA PET
is the superior modality for detecting metastases to the locoregional and extrapelvic
lymph nodes, bones, and visceral organs [33]. More than 90% of primary PCa lesions
show moderate to high PSMA expression levels on PSMA PET, and many current
studies have indicated that PET/MRI could be the single ideal imaging modality for sta-
ging PCa patients [33]. Several studies have demonstrated that the intensity of radio-
tracer accumulation in the primary tumor is correlated to PSA levels and Gleason
score and therefore with PCa groups of risk [34, 35]. This is the major cause of our
work: considering the potential role of a PSMA PET/US portable device as a prebiopsy
diagnostic tool that can be used to guide sampling the most aggressive sites in the
Fig. 13 Top, QP with insert-to-background ratio of 38 acquired and reconstructed in the Gemini-TF (left)
and with the ProsPET system (1mm voxel, 8 iterations, attenuation based on CT image, no scatter
correction). Bottom, same as top but for an insert-to-background ratio of 18
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prostate, avoiding a high number of samples as in systematic biopsy. Hence, ProsPET
could be indicated for detecting intraprostatic malignant lesions in untreated patients
with newly diagnosed PCa or oriented to a focal therapy, at an economic cost that
makes it accessible to any hospital.
We have designed and built a prostate specific PET system, called ProsPET. This
scanner design presents a very small footprint and improved spatial resolution when
compared with a conventional whole-body PET scanner. This is caused by the proxim-
ity of the detectors to the prostate and more accurate identification of the gamma ray
impact within each detector block, including accurate DOI determination. Monolithic
scintillator blocks are being used in this design, which combined with our readout elec-
tronics and data processing techniques offer the capabilities to accurately determine
the 3D gamma ray interaction coordinates within the scintillator block and, thus, to
correct the parallax error. When this correction is not enabled in the reconstructed
data, the spatial resolution at the edges of the FOV worsens; see Fig. 9.
As in most clinical PET systems, there is a need for normalization and attenuation
corrections. This becomes more important for regions such as the thorax or the hip
Fig. 14 Left, CNR comparison between the ProsPET system using 8 iterations (attenuation based on CT
image and no scatter correction) and the Gemini-TF, for the 6 inserts, and the two insert-to-background
ratios 18 and 38, respectively. Right, contrast (%) comparison also for all 6 inserts and two ratios
Fig. 15 Image reconstructions using the prostate PET prototype of the patient data before normalization
(a), with only normalization (b), also including CT-based attenuation (c). Image of one bed position with the
Gemini-TF is depicted in d
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where multiple organs and surrounding bones are present. We have calculated a gen-
eric normalization map for every measurement and a specific attenuation map for each
experiment.
The ProsPET prototype exhibits a comparable sensitivity (1.5% at the FOV center)
than conventional PET systems. The Gemini-TF reaches 0.7% at the FOV center [29].
We have observed some differences between the sensitivity values obtained with the
simulations and with experimental data, most likely caused by losses in the real data
not considered in the simulations. In terms of spatial resolution, the FWHM of the
sources at the FOV center is around 2mm while the Gemini-TF reports around 4.7
mm [29]. With the DOI correction enabled in the ProsPET, the spatial resolution is al-
ways below 3mm for the entire FOV.
One limitation that we have observed studying the count rate curves is that ProsPET
shows a high contribution of random and scatter events, even for low activities. We are
currently working on implementing these two contributions. We found the NECR max-
imum point at 16 kcps for an activity of 2.4 mCi. The high contributions of random
and scatter events affect the CNR but not the image contrast. The differences between
real and simulated data at high activities might also be caused by an underestimation of
the simulated electronics dead time.
The SNR exhibits certain differences for the larger inserts of the QP, most likely, as a
consequence of the high random and scatter contribution, observed in the NECR rates.
However, due to the high spatial resolution of the ProsPET, this shows a higher con-
trast for the smaller insert diameters, which becomes comparable for largest inserts.
Finally, we have tested the ProsPET with a patient with prostate cancer. Multiple le-
sions were detected both using the whole-body PET but also the ProsPET. Although
the result was positive and the lesions detected, the dedicated system still requires some
further improvement when correcting the patient attenuation. This was easily achieved
with phantoms but a better co-registration is needed when using patients. Regarding
comfortability, patients felt comfortable within the dedicated PET system.
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